Finance

Beta
Lists
ACET:NASDAQ
Adicet Bio Inc
$8.62
-0.23%
(-0.020) 1D
Jul 1, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACET...
Open
$8.58
High
$9.02
Low
$8.40
Mkt. cap
80.58M
Avg. vol.
98.12K
Volume
0.00
52-wk high
$17.44
52-wk low
$6.01
EPS
-$16.51
Beta
1.56
Shares outstanding
9.35M
No. of employees
102
Open
$8.58
High
$9.02
Low
$8.40
Mkt. cap
80.58M
Avg. vol.
98.12K
Volume
0.00
52-wk high
$17.44
52-wk low
$6.01
EPS
-$16.51
Beta
1.56
Shares outstanding
9.35M
No. of employees
102
News stories
From sources across the web
About Adicet Bio Inc
CEO-
Employees102
Founded2014
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websiteadicetbio.com
Analyst ratings
Based on 4 analysts giving stock ratings to ACET in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ACET in the last 3 months.
Highest
Current $8.62
$25.00 (+190.02%)
Average
$20.50 (+137.82%)
Lowest
$18.00 (+108.82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boris Peaker
JonesTrading
Buy
Maintained
$20.00
+132%
05/14/2026
Unknown Analyst
Wedbush
Buy
Reiterated
$25.00
+190%
05/14/2026
John Newman
Canaccord Genuity
Buy
Maintained
$18.00
+108.8%
05/14/2026
Anthea Li
Jefferies
Buy
Initiated
$19.00
+120.4%
05/04/2026
Soumit Roy
JonesTrading
Buy
Maintained
$20.00
+132%
04/06/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$27.00
+213.2%
03/23/2026
Asthika Goonewardene
Truist Financial
Buy
Reiterated
-
-
03/16/2026
Yatin Suneja
Guggenheim
Buy
Maintained
$100.00
+1,060.1%
03/13/2026
Robert Driscoll
Wedbush
Buy
Reiterated
$25.00
+190%
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
28.42M
22.85M
25.04M
17.49M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.97M
5.10M
6.85M
4.08M
Operating expense
32.39M
27.95M
31.89M
21.57M
Total operating expenses
32.39M
27.95M
31.89M
21.57M
Operating income
-32.39M
-27.95M
-31.89M
-21.57M
Other non operating income
-223.00K
-64.00K
-130.00K
7.00K
EBT including unusual items
-31.22M
-26.86M
-30.52M
-20.24M
EBT excluding unusual items
-31.22M
-26.86M
-30.52M
-20.24M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-31.22M
-26.86M
-30.52M
-20.24M
Net profit margin
-
-
-
-
Earnings per share
-5.44
-4.64
-2.94
-1.88
Interest and investment income
1.40M
1.17M
1.52M
1.34M
Interest expense
-
-12.00K
-24.00K
-23.00K
Net interest expenses
1.40M
1.16M
1.50M
1.32M
Depreciation and amortization charges
-
-
-
-
EBITDA
-30.74M
-26.38M
-30.41M
-20.23M
Gain or loss from assets sale
103.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer